eMagin - EMAN Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for eMagin in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EMAN shares.
View EMAN analyst ratings or view top-rated stocks.

2 brokerages have issued 1-year price targets for eMagin's shares. Their EMAN share price forecasts range from $3.00 to $3.00. On average, they expect the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 50.8% from the stock's current price.
View analysts price targets for EMAN or view top-rated stocks among Wall Street analysts.

eMagin's stock was trading at $0.8999 at the beginning of 2023. Since then, EMAN shares have increased by 121.1% and is now trading at $1.99.
View the best growth stocks for 2023 here.

eMagin saw a decrease in short interest in the month of February. As of February 28th, there was short interest totaling 2,410,000 shares, a decrease of 6.2% from the February 13th total of 2,570,000 shares. Based on an average daily trading volume, of 158,500 shares, the days-to-cover ratio is currently 15.2 days.
View eMagin's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023.
View our EMAN earnings forecast.

eMagin Co. (NYSEAMERICAN:EMAN) released its earnings results on Friday, November, 12th. The semiconductor company reported ($0.05) earnings per share for the quarter. eMagin had a negative net margin of 3.61% and a negative trailing twelve-month return on equity of 12.73%.

eMagin updated its fourth quarter 2022 earnings guidance on Thursday, January, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $8.10 million-$8.30 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other eMagin investors own include Guyana Goldfields (GUY), Hawkins (HWKN), CA (CA), Kopin (KOPN), Universal Display (OLED), Ampio Pharmaceuticals (AMPE), OPKO Health (OPK), Riot Platforms (RIOT), BlackRock (BLK) and Advanced Micro Devices (AMD).

eMagin trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "EMAN."

eMagin's stock is owned by a number of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.08%), Jane Street Group LLC (0.07%), Millennium Management LLC (0.05%), Group One Trading L.P. (0.04%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Amalkumar Ghosh, Andrew George Sculley Jr, Eric Braddom, Joseph Saltarelli, Ltd Enervest, Ltd Ginola, Mark A Koch, Prache Olivier and Stillwater Holdings Llc.
View institutional ownership trends.

Shares of EMAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EMAN stock can currently be purchased for approximately $1.99.

eMagin (NYSEAMERICAN:EMAN) has a market capitalization of $155.66 million and generates $30.53 million in revenue each year. The semiconductor company earns $-1,100,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis.

The company employs 101 workers across the globe.

eMagin's mailing address is 2070 Route 52 Building 334, HOPEWELL JUNCTION, NY 12533-3507, United States. The official website for the company is www.emagin.com. The semiconductor company can be reached via phone at (845) 838-7900, via email at investorrelations@emagin.com, or via fax at 845-838-7901.